Skip to main content

Search Videos and More

Showing 17 - 32 of 139 results

Previous| 1 | 2 | 3 ...9 |Next

Mount Sinai Shifts Standard of Treatment for Severe Tricuspid Regurgitation With New, Nonsurgical Options

Mount Sinai Shifts Standard of Treatment for Severe Tricuspid Regurgitation With New, Nonsurgical Options

Hidden Genetic Causes of Congenital Heart Disease Identified

Hidden Genetic Causes of Congenital Heart Disease Identified

Study led by Mount Sinai Researcher shows Sotagliflozin is the Only Drug in its class to Significantly Reduce Both Heart Attacks and Strokes

Study led by Mount Sinai Researcher shows Sotagliflozin is the Only Drug in its class to Significantly Reduce Both Heart Attacks and Strokes

Changing the Cardiovascular Risk Profile for Women With Severe or Early Preeclampsia

PRECAD Trial to Explore If Controlling Risk Factors at Early Age Can Prevent Cardiovascular Events in Later Life

PRECAD Trial to Explore If Controlling Risk Factors at Early Age Can Prevent Cardiovascular Events in Later Life

Valentin Fuster, MD, PhD, Wins Prestigious Award From the International Atherosclerosis Society

Valentin Fuster, MD, PhD, Wins Prestigious Award From the International Atherosclerosis Society

Stopping Aspirin One Month After PCI Is Found Safe in Patients With Acute Coronary Syndromes

Stopping Aspirin One Month After PCI Is Found Safe in Patients With Acute Coronary Syndromes

After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing

After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing

Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, Study Finds

Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, Study Finds

Mount Sinai Study Shows Presence of Subclinical Atherosclerosis Is Marker of Mortality and Its Progression Increases Risk of Death

Mount Sinai Study Shows Presence of Subclinical Atherosclerosis Is Marker of Mortality and Its Progression Increases Risk of Death

SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for Treating Patients Who Have Suffered a Heart Attack

SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for Treating Patients Who Have Suffered a Heart Attack

Roxana Mehran, MD, Is Incoming Vice President of the American College of Cardiology

Roxana Mehran, MD, Is Incoming Vice President of the American College of Cardiology

Mount Sinai-led Study on Pulsed Field Ablation Procedures Demonstrate Significant Safety Outcomes for Atrial Fibrillation Patients

Mount Sinai-led Study on Pulsed Field Ablation Procedures Demonstrate Significant Safety Outcomes for Atrial Fibrillation Patients

Mount Sinai Fuster Heart Hospital: 2023 Clinical Outcomes and Innovations Report

Mount Sinai Fuster Heart Hospital: 2023 Clinical Outcomes and Innovations Report

New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes

New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes

Valentín Fuster, MD, PhD, MACC, President of Mount Sinai Fuster Heart Hospital, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)

Valentín Fuster, MD, PhD, MACC, President of Mount Sinai Fuster Heart Hospital, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)

Showing 17 - 32 of 139 results

Previous| 1 | 2 | 3 ...9 |Next